Published August 1, 2013 | Version v1
Journal article Open

Transcriptional Events during the Recovery from MRSA Lung Infection: A Mouse Pneumonia Model

  • 1. Northwestern University
  • 2. University of Illinois at Chicago
  • 3. University of Chicago
  • 4. National Institute of Allergy and Infectious Diseases

Description

Community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging threat to human health throughout the world. Rodent MRSA pneumonia models mainly focus on the early innate immune responses to MRSA lung infection. However, the molecular pattern and mechanisms of recovery from MRSA lung infection are largely unknown. In this study, a sublethal mouse MRSA pneumonia model was employed to investigate late events during the recovery from MRSA lung infection. We compared lung bacterial clearance, bronchoalveolar lavage fluid (BALF) characterization, lung histology, lung cell proliferation, lung vascular permeability and lung gene expression profiling between days 1 and 3 post MRSA lung infection. Compared to day 1 post infection, bacterial colony counts, BALF total cell number and BALF protein concentration significantly decreased at day 3 post infection. Lung cDNA microarray analysis identified 47 significantly up-regulated and 35 down-regulated genes (p<0.01, 1.5 fold change [up and down]). The pattern of gene expression suggests that lung recovery is characterized by enhanced cell division, vascularization, wound healing and adjustment of host adaptive immune responses. Proliferation assay by PCNA staining further confirmed that at day 3 lungs have significantly higher cell proliferation than at day 1. Furthermore, at day 3 lungs displayed significantly lower levels of vascular permeability to albumin, compared to day 1. Collectively, this data helps us elucidate the molecular mechanisms of the recovery after MRSA lung infection.

Files

journal.pone.0070176.pdf

Files (1.1 MB)

Name Size Download all
Article
md5:2d416495c797bbf9867c4bb3189b297f
1.1 MB Preview Download
Supporting information
md5:1b50966dbd0192aa9252a7adccff19ae
16.5 kB Download

Additional details

Identifiers

DOI
10.1371/journal.pone.0070176
Other
oai:uchicago.tind.io:10762

Funding

Pfizer
ASPIRE Award
Pfizer
Investigator-Initiated Grant
National Center for Advancing Translational Sciences
8UL1TR000150
National Cancer Institute
Cancer Center Support Grant
National Institute of Allergy and Infectious Diseases
Intramural Research Program

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pediatrics